Notes

Prescience Point Scores Big on MiMedx Bet, Going against typically the short sellers offers led to large gains for Eiad Asbahi? s account.
MARIETTA, Georgia., May 30, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader within advanced wound care and an appearing therapeutic biologics firm, today announced that the Company's board of directors (the "Board") has adopted a comprehensive plan in order to refresh the structure with the Board. The particular plan was developed by simply the Board throughout cooperation with one of many Company's largest shareholders, Prescience Point Funds Management LLC ("Prescience Point"), and follows the completion associated with the Audit Committee's independent investigation straight into alleged wrongdoing simply by the prior older management team and the engagement regarding BDO USA, LLP as the Carrier's new independent signed up public accounting organization.

Under the plan, 6 new directors, which include MiMedx's new CEO, Timothy R. Wright, can be added in order to the Board. As a result, School II and School III of typically the Board would are made up entirely of new directors after the Company's 2019 annual getting together with of shareholders. The refreshment plan includes the appointment of three of Supposition Point's nominees, including M. Kathleen Behrens Wilsey, Ph. G. as the fresh Chairwoman of typically the Board, as well as T. Todd Newton, that is expected to become the Chairman of the Audit Panel after the Carrier's 2019 annual getting together with of shareholders.

"The MiMedx Board and the current senior leadership team have been working tirelessly in order to address the after effects from the behavior of the earlier senior management staff and obtain the Business back on course, inches said Charles R. Evans, Chairman of the Board. "Now that we possess made substantial advancement on these fronts, it is period to begin the Board transition and refreshment process. We all are pleased to be able to have worked collaboratively with Prescience Point to be able to identify and add brand-new directors who deliver exceptional experience and even track records in order to MiMedx. With the Review Committee's investigation complete and an intend to refresh the Board within place, the Company is currently in the position to target on its future in addition to enhance its enterprise, for the benefit for all stakeholders. inches

"We welcome the great plan to refresh the Board, and we count on MiMedx's future under brand new leadership. We have been happy that our co-operation has resulted throughout a reconstituted Board, with the addition of six brand new directors with essential industry experience, interactions and reputational money, " said Eiad Asbahi, Founder and Managing Partner involving Prescience Point. "We committed to MiMedx due to the fact we feel the Firm has immense prospective as a head in advanced wound care and restorative biologics. We feel MiMedx is upon the path in order to unlock substantial shareholder value and safe a thriving upcoming to the Company. "

Underneath the refreshment strategy, Prescience Point nominee M. Kathleen Behrens Wilsey, Ph. D. will be appointed or nominated for selection to the Board and even is expected to become named the brand new Chairwoman of the Plank. Dr. Behrens Wilsey is currently typically the Chairwoman of Sarepta Therapeutics, Inc. (SRPT), a multi-billion-dollar health care research and drug development company concentrated on the finding and development involving unique RNA-targeted therapeutics for your treatment of rare neuromuscular conditions. Dr. Behrens Wilsey previously served about the boards of Amylin Pharmaceuticals, Inc. (formerly AMLN) in addition to Abgenix, Inc. (formerly ABGX).

In add-on to Dr . prescience point , the Table will also designate, or nominate for election to the Board, Richard J. Barry, James M. Bierman, K. Jake Newton, Mr. Wright and another movie director who will be hired by the Company and even Prescience Point. Full biographies of the particular anticipated new directors appear at the final of this push release.

The Company expects to file its preliminary proxy materials for its 2018 Annual Meeting today. The Board promotes shareholders to hold out to receive you’re able to send proxy materials plus the Company's BLUE serwery proxy card before voting.

Sidley Austin LLP is acting since legal advisor to MiMedx. Olshan Frome Wolosky LLP is certainly acting as lawful advisor to Prescience Point.

About Rich J. Barry
Mr. Barry has dished up as a representative of Elcelyx Therapeutics, Inc., a non-public pharmaceutical company, given that February 2013 and has served as a Managing Member associated with GSM Fund, LLC, a fund established for that sole purpose of buying Elcelyx Therapeutics, since February 2013. Earlier in his career, he was a founding member of Eastbourne Capital Supervision LLC, a great equity hedge pay for purchasing a variety associated with industries, including health care, and served as the Handling General Partner and Portfolio Manager by 1999 to their close in the year 2010. Prior to of which, he was a new Portfolio Manager in addition to Managing Director of Robertson Stephens Investment Management, an investment decision company, from 95 until 1999. Before that, Mr. Barry spent over thirteen years in several functions in institutional collateral and investment administration firms, including Lazard Freres, Legg Builder and Merrill Lynch. Mr. Barry has served like a movie director of Sarepta Therapeutics, Inc. (SRPT), the genetic medicine company, since June 2015, and he is a huge Partner and Prediction Board member involving the San Diego Padres since this year. Mr. Barry in the past served like a movie director of Cluster Wi-fi, LLC, an application business, from 2011 until 2014, associated with BlackLight Power, Inc. (n/k/a Brilliant Light Electrical power, Inc. ), an energy research company, from 2009 right up until 2010. Mr. Barry holds a B. A. from Pa State University.

Regarding M. Kathleen Behrens Wilsey, Ph. Deb.
Dr. Behrens Wilsey served as a new member with the plank of directors involving each of Sarepta Therapeutics, Inc. (SRPT), a multi-billion buck medical research and drug development organization targeted on the breakthrough discovery and development regarding unique RNA-targeted therapeutics for the take care of rare neuromuscular illnesses, since March this year (Chairwoman of typically the Board since April 2015) and IGM Biosciences, Inc., a private biotechnology company, since January 2019. Doctor Behrens Wilsey worked as an self-employed life sciences advisor and investor due to the fact December 2009. The lady served as the Co-Founder, President, Key Executive Officer and as an overseer of the KEW Group Inc., a personal oncology services organization, from January the summer season until June 2014. Earlier in the girl career, Dr. Behrens Wilsey served like a general partner with regard to selected venture funds for RS Opportunities, a mutual fund firm, from 1996 until December year. While Dr. Behrens Wilsey worked in RS Investments, through 1996 to 2002, she served like a managing director in the firm and, coming from 2003 to December 2009, she offered as a specialist towards the firm. During that time, Medical professional. Behrens Wilsey also served as a member associated with the President's Council of Advisors on Science and Technologies (PCAST), from i b?rjan p? tv?tusentalet to 2009 and since chairwoman of PCAST's Subcommittee on Customized Medicine, as nicely as the Us president, director and chairwoman of the Countrywide Investment capital Association, a great organization that recommends for public policy that supports the American Entrepreneurial ecosystem, from 1993 until 2000. Just before that will, she served while a general spouse and managing representative for Robertson Stephens & Co., a great investment company, from 1983 through 1996. The girl served as some sort of director of Amylin Pharmaceuticals, Inc. (formerly AMLN), a biopharmaceutical company, from 2009 until the company's selling in 2012 to Bristol-Myers Squibb Co. Previous to that, the girl served on the plank of directors Abgenix, Inc. (formerly ABGX), a biopharmaceutical business, from 2001 till the company was sold to Amgen, Inc. in 2006. From 1997 to be able to 2005, Doctor Behrens was a representative of the Table on Science, Technology and Economic Plan to the National Research Council. Dr. Behrens Wilsey was likewise a Co-Founder regarding the Coalition with regard to 21st Century Medication, a trade organization for new generation diagnostics companies. Dr. Behrens Wilsey holds some sort of B. S. throughout Biology and some sort of Ph. D. inside Microbiology from your College or university of California, Davis.

About James L. Bierman
Mr. Bierman served as President and Chief Executive Officer involving Owens & Small, Inc., a lot of money five hundred company plus a major distributor of health-related and surgical materials, from September 2014 to June 2015. Previously, he dished up in various other senior roles with Owens & Minor, including President and Chief Operating Police officer from August 2013 to September 2014, Executive Vice Leader and Chief Running Officer from 03 2012 to September 2013, Executive Bassesse President and Primary Financial Officer coming from April 2011 to be able to March 2012, and Senior Vice President and Chief Monetary Officer from June 2007 to Apr 2011. From 2001 to 2004, Mister. Bierman served as Executive Vice Chief executive and Chief Economical Officer at Quintiles Transnational Corp. Earlier to joining Quintiles Transnational, Mr. Bierman was a spouse at Arthur Andersen LLP. Mr. Bierman currently serves upon the board involving directors of Tenet Healthcare Corporation (THC) and previously served on the planks of directors associated with Owens & Slight, Inc. (OMI) in addition to Team Health Loge, Inc. (formerly TMH). Mr. Bierman gained his B. A new. from Dickinson College or university and his Meters. B. A. from Cornell University's Nicholson Graduate School of Management.

About K. Todd Newton
Mister. Newton has, given that 2014, served as Ceo and the member of the particular board of owners of Apollo Endosurgery, Inc. (APEN), a leader in the discipline of gastrointestinal beneficial endoscopy. From 2009 to 2014, Mister. Newton served as Executive Vice Us president and Chief Economical Officer at ArthroCare Corporation (ARTC), the medical device firm, including from 2013 as Chief Running Officer. Prior to be able to his leadership at ArthroCare, Mr. Newton served in a number of executive officer roles, including President and Main Executive Officer, with Synenco Energy, Incorporation., a Canadian essential oil sands company. Coming from 1994 to 2005, Mr. Newton was a Partner from Deloitte & Patte LLP. Mr. Newton holds a W. B. A. within accounting through the College or university of Texas from San Antonio.

About Timothy R. Wright
Mr. Wright grew to be MiMedx's Ceo, efficient as of May well 13, 2019. Formerly, Mr. Wright served as a Partner at Signal Hill Advisors, LLC, a new consulting practice, given that February 2011. Mr. Wright served seeing that President and Chief Executive Officer associated with M2Gen Corp., a privately held cancers and health informatics company, between September 2017 and The month of september 2018. Prior in order to M2Gen Corp., Mister. Wright served while Executive Vp, Mergers and Acquisitions, Technique and Innovation with regard to Teva Pharmaceutical Companies Ltd. ("Teva"), the pharmaceutical company specialized in in generic medications, from April 2015 until August 2017. Before Teva, Mr. Wright was typically the founding partner involving The Ohio Condition University Comprehensive Cancers Drug Development Company. Mr. Wright likewise served as Leader, Interim Chief Executive Officer plus a director regarding Curaxis Pharmaceutical Corporation ("Curaxis"), a prescription company specializing inside the introduction of drugs regarding the remedying of Alzheimer's disease and various cancers, from This summer 2011 to Come july 1st 2012. Curaxis acquired been experiencing monetary difficulties prior to Mr. Wright's period and, as a new result, the firm filed for Part 11 bankruptcy throughout July 2012. Mr. Wright has already been a director regarding Agenus, Inc. (Nasdaq: AGEN), an defense oncology company, due to the fact 2006 and their lead director since 2009. Mr. Wright also serves as Chairperson with the Kentkucky State University Broad Cancer Center Medication Development Institute, serves as director from the Ohio State Advancement Foundation and is located on The Ohio State University College of Pharmacy Dean's Corporate Council. Mister. Wright earned some sort of Bachelor's of Technology in Marketing from The Ohio State University.

About MiMedx
MiMedx� is an industry leader in sophisticated wound care in addition to an emerging healing biologics company building and distributing individuals placental tissue allografts with patent-protected techniques for multiple groups of healthcare. The particular Company processes your placental tissue using its proprietary PURION� process methodology, among other processes, to make allografts by making use of aseptic processing approaches in addition to airport terminal sterilization. MiMedx has supplied over 1. 5 million allografts to date. For more information, please check out www.mimedx.com.

About Supposition Point Capital Management
Prescience Point Money Management is a new private investment supervisor that employs forensic investigative techniques to discover significant mispricings on global markets. It specializes in intensive investigations of difficult-to-analyze public companies to be able to uncover significant portions of the business that will have been unnoticed or ignored by others.

Prescience Stage manages private money on behalf of its clients in addition to principals and takes positions both long and short inside support of their research. Prescience Stage invests across a broad set associated with equities that that believes have uncommonly large disparities among what their fundamental businesses are intrinsically worth and what their stock options cost. The determined begun by investor Eiad Asbahi throughout 2009 and is based in Baton Rouge, LA. Prescience Level Capital Management is a registered investment advisor with the particular State of Louisiana. Follow @PresciencePoint.

Safe Harbor Statement

This kind of press release includes forward-looking statements, including claims in connection with plan regarding MiMedx Group, Inc. (the "Company") to refresh the Table, the consequence of such refreshment around the Company in addition to expectations with value to Board leadership. Forward-looking statements might be identified by words such as "believe, " "expect, inch "may, " "plan, " "potential, " "will, " "would" and similar expression and they are based in current beliefs in addition to expectations. Forward-looking transactions are controlled by hazards and uncertainties, and the Company engagement investors against inserting undue reliance on the subject of such statements.

Genuine results may fluctuate materially from all those set forth in the forward-looking statements while a result regarding various factors, like the results associated with any election regarding Class II or Class III administrators. There is zero assurance that the particular Board's nominees will be elected with the Company's 2018 yearly meeting of shareholders (the "2018 Gross annual Meeting") or the particular Company's 2019 total annual meeting of shareholders. Any forward-looking claims speak only while of the date of this press release, and except since required by law, the Company assumes no more obligation to revise any forward-looking affirmation, whether as a new result of new information, future events or else.

Important Info
The Company expects to file a new definitive proxy declaration and associated GLOWING BLUE proxy card inside of connection with typically the solicitation of unblock proxies for the 2018 Annual Meeting with the Securities and Exchange Commission (the "SEC"). Details with regards to the nominees with the Company's board associated with directors for selection at the 2018 Annual Meeting is going to be contained in the proxy server statement. BEFORE MAKING ANY KIND OF VOTING DECISION, INVESTORS OF THE COMPANY ARE URGED TO STUDY ALL RELEVANT PAPERWORK FILED WITH OR PERHAPS FURNISHED TO THE PARTICULAR SEC, INCLUDING TYPICALLY THE COMPANY'S DEFINITIVE PROXY SERVER STATEMENT AND ANY KIND OF SUPPLEMENTS THERETO, SINCE THEY WILL INCLUDE IMPORTANT INFORMATION. Traders and shareholders will certainly be able to be able to get yourself a copy associated with the definitive web proxy statement and also other files filed by Organization free of demand through the SEC's website at www.sec.gov. Typically the Company's shareholders can also be in a position to obtain, with no charge, a backup from the definitive proxy statement and some other relevant filed files from the "SEC Filings" section regarding you’re able to send website at www.mimedx.com.

Participants throughout the Solicitation
Typically the Company, its owners, its director nominees and certain from the executive officers are usually participants in typically the solicitation of unblock proxies from shareholders within respect of the particular 2018 Annual Conference. Information regarding typically the names of typically the Company's directors, overseer nominees and executive officers and the particular interests in the Organization by security coopération or otherwise is placed forth in the particular Company's Current Report on Form 8-K filed with the SEC on, may 35, 2019. Additional information with regards to the interests of these participants in any kind of proxy solicitation and a description regarding their direct and even indirect interests, by simply security holdings or even otherwise, will furthermore be incorporated into any kind of proxy statement and other relevant textiles to be submitted with all the SEC, in the event that and when they will available.
Homepage: https://backlinktool.io/p/K09OTVpWa0zwEr5U2Ls3.html